Fine Mark National Bank & Trust Danaher Corp Transaction History

Fine Mark National Bank & Trust

  • $2.7 Billion
  • Q2 2024

A detailed history of Fine Mark National Bank & Trust transactions in Danaher Corp stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 79,877 shares of DHR stock, worth $22 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
79,877
Previous 78,932 1.2%
Holding current value
$22 Million
Previous $19.7 Million 1.25%
% of portfolio
0.74%
Previous 0.75%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024
BUY
$235.51 - $267.98 $222,556 - $253,241
945 Added 1.2%
79,877 $20 Million
Q1 2024

May 14, 2024
BUY
$224.58 - $256.19 $3.82 Million - $4.36 Million
17,009 Added 27.47%
78,932 $19.7 Million
Q4 2023

Feb 09, 2024
SELL
$185.1 - $233.13 $2,776 - $3,496
-15 Reduced 0.02%
61,923 $14.3 Million
Q3 2023

Nov 15, 2023
SELL
$233.08 - $265.59 $263,147 - $299,851
-1,129 Reduced 1.79%
61,938 $15.4 Million
Q2 2023

Aug 11, 2023
SELL
$224.99 - $256.14 $344,459 - $392,150
-1,531 Reduced 2.37%
63,067 $15.1 Million
Q1 2023

May 08, 2023
SELL
$239.75 - $277.0 $327,498 - $378,382
-1,366 Reduced 2.07%
64,598 $16.3 Million
Q4 2022

Feb 09, 2023
SELL
$241.42 - $282.29 $571,923 - $668,745
-2,369 Reduced 3.47%
65,964 $17.5 Million
Q3 2022

Nov 14, 2022
SELL
$247.06 - $1507.4 $344,401 - $2.1 Million
-1,394 Reduced 2.0%
68,333 $17.7 Million
Q2 2022

Aug 09, 2022
SELL
$237.11 - $299.66 $247,305 - $312,545
-1,043 Reduced 1.47%
69,727 $17.7 Million
Q1 2022

May 16, 2022
BUY
$257.27 - $315.76 $368,667 - $452,484
1,433 Added 2.07%
70,770 $20.8 Million
Q4 2021

Feb 14, 2022
SELL
$292.08 - $329.01 $2.99 Million - $3.37 Million
-10,240 Reduced 12.87%
69,337 $22.8 Million
Q3 2021

Nov 12, 2021
BUY
$272.21 - $332.43 $18,238 - $22,272
67 Added 0.08%
79,577 $24.2 Million
Q2 2021

Aug 13, 2021
SELL
$225.08 - $271.69 $15,980 - $19,289
-71 Reduced 0.09%
79,510 $21.3 Million
Q1 2021

May 12, 2021
BUY
$212.38 - $245.9 $90,049 - $104,261
424 Added 0.54%
79,581 $17.9 Million
Q4 2020

Feb 10, 2021
SELL
$212.5 - $245.46 $97,537 - $112,666
-459 Reduced 0.58%
79,157 $17.6 Million
Q3 2020

Nov 12, 2020
SELL
$177.16 - $215.33 $102,752 - $124,891
-580 Reduced 0.72%
79,616 $17.1 Million
Q2 2020

Aug 13, 2020
SELL
$128.7 - $176.83 $49,420 - $67,902
-384 Reduced 0.48%
80,196 $14.2 Million
Q1 2020

May 06, 2020
BUY
$121.39 - $169.05 $73,076 - $101,768
602 Added 0.75%
80,580 $11.2 Million
Q4 2019

Feb 07, 2020
BUY
$133.47 - $153.48 $299,773 - $344,716
2,246 Added 2.89%
79,978 $12.3 Million
Q3 2019

Nov 08, 2019
BUY
$135.4 - $146.47 $193,757 - $209,598
1,431 Added 1.88%
77,732 $11.2 Million
Q2 2019

Aug 08, 2019
BUY
$124.88 - $143.73 $255,629 - $294,215
2,047 Added 2.76%
76,301 $10.9 Million
Q1 2019

May 07, 2019
SELL
$97.62 - $132.29 $162,342 - $219,998
-1,663 Reduced 2.19%
74,254 $9.8 Million
Q4 2018

Feb 07, 2019
BUY
$94.85 - $109.54 $238,358 - $275,274
2,513 Added 3.42%
75,917 $7.83 Million
Q3 2018

Nov 02, 2018
BUY
$98.13 - $108.9 $242,184 - $268,765
2,468 Added 3.48%
73,404 $7.98 Million
Q2 2018

Aug 03, 2018
SELL
$96.1 - $103.24 $125,794 - $135,141
-1,309 Reduced 1.81%
70,936 $7 Million
Q1 2018

Apr 26, 2018
BUY
$92.16 - $103.8 $26,910 - $30,309
292 Added 0.41%
72,245 $7.07 Million
Q4 2017

Jan 30, 2018
SELL
$85.26 - $94.62 $142,639 - $158,299
-1,673 Reduced 2.27%
71,953 $6.68 Million
Q3 2017

Oct 30, 2017
BUY
$79.29 - $88.45 $5.84 Million - $6.51 Million
73,626
73,626 $6.32 Million

Others Institutions Holding DHR

# of Institutions
2,389
Shares Held
563M
Call Options Held
3.94M
Put Options Held
4.1M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $201B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email